Teladoc Health, Inc. (TDOC) — Analyst outlook / Analyst consensus target is. Based on 42 analyst ratings, the consensus is bullish — 14 Buy, 28 Hold.
The consensus price target is $7.90 (low: $6.00, high: $11.00), representing an upside of 50.8% from the current price $5.24.
Analysts estimate Earnings Per Share (EPS) of $-5.82 and revenue of $2.57B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-5.87 vs est $-5.82 (missed -0.9%). 2025: actual $-1.14 vs est $-1.18 (beat +3.3%). Analyst accuracy: 98%.
TDOC Stock — 12-Month Price Forecast
$7.90
▲ +50.76% Upside
Average Price Target
Based on 42 Wall Street analysts offering 12-month price targets for Teladoc Health, Inc., the average price target is $7.90, with a high forecast of $11.00, and a low forecast of $6.00.
The average price target represents a +50.76% change from the last price of $5.24.
Highest Price Target
$11.00
Average Price Target
$7.90
Lowest Price Target
$6.00
TDOC Analyst Ratings
Hold
Based on 42 analysts giving stock ratings to Teladoc Health, Inc. in the past 3 months
EPS Estimates — TDOC
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$5.87
vs Est –$5.82
▼ 0.9% off
2025
Actual –$1.14
vs Est –$1.18
▲ 3.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — TDOC
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.570B
vs Est $2.569B
▲ 0.0% off
2025
Actual $2.530B
vs Est $2.523B
▲ 0.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
